clear space clear space clear space white space
A
 r c h i v e s   o f   M a r y l a n d   O n l i n e

PLEASE NOTE: The searchable text below was computer generated and may contain typographical errors. Numerical typos are particularly troubling. Click “View pdf” to see the original document.

  Maryland State Archives | Index | Help | Search
search for:
clear space
white space
Session Laws, 1982
Volume 742, Page 1875   View pdf image
 Jump to  
  << PREVIOUS  NEXT >>
clear space clear space clear space white space

HARRY HUGHES, Governor

1875

(5)  THE METHODS, FACILITIES, OR CONTROLS USED IN
THE MANUFACTURE, PROCESSING, PACKING, OR HOLDING OF THE DRUG
DO NOT CONFORM TO, OR ARE NOT ADMINISTERED IN CONFORMITY TO,
GOOD PRACTICE TO ASSURE THAT THE DRUG:

(I)  MEETS THE REQUIREMENTS OF THIS
SUBTITLE AS TO SAFETY; AND

(II)  HAS THE IDENTITY, STRENGTH, QUALITY,
AND PURITY THAT IT PURPORTS TO HAVE;

(6)  IT IS PURPORTED TO BE A DRUG THE NAME OF
WHICH IS RECOGNIZED IN AN OFFICIAL COMPENDIUM AND:

(I)  THE STRENGTH OF THE DRUG DIFFERS FROM,
OR THE QUALITY OR PURITY OF THE DRUG FALLS BELOW, THE
STANDARD SET IN THE OFFICIAL COMPENDIUM; AND

(II)  THE DIFFERENCE IN STRENGTH, QUALITY,
OR PURITY IS NOT STATED PLAINLY ON ITS LABEL; OR

(7)  ALTHOUGH NOT PURPORTED TO BE A DRUG
RECOGNIZED IN AN OFFICIAL COMPENDIUM, THE STRENGTH OF THE
DRUG DIFFERS FROM, OR THE QUALITY OR PURITY OF THE DRUG
FALLS BELOW THAT WHICH THE DRUG PURPORTS TO POSSESS.

(D) TESTING DRUGS PURPORTED TO BE RECOGNIZED IN
OFFICIAL COMPENDIUM; APPLICATION OF REQUIREMENTS IN OFFICIAL
COMPENDIUM.

(1)  FOR PURPOSES OF ADMINISTERING SUBSECTION
(C)(6) OF THIS SECTION, ANY DETERMINATION AS TO WHETHER THE
STRENGTH OF A DRUG DIFFERS FROM OR AS TO WHETHER ITS QUALITY
OR PURITY FALLS BELOW THE STANDARD SET IN AN OFFICIAL
COMPENDIUM SHALL BE MADE IN ACCORDANCE WITH THE TESTS OR
METHODS OF ASSAY SET FORTH IN THE OFFICIAL COMPENDIUM, OR,
IN THE ABSENCE OF OR INADEQUACY OF THOSE TESTS OR METHODS OF
ASSAY, THOSE PROVIDED UNDER THE FEDERAL ACT.

(2) (I) EXCEPT AS PROVIDED IN SUBPARAGRAPH (II)
OF THIS PARAGRAPH, IF A DRUG IS RECOGNIZED IN BOTH THE
UNITED STATES PHARMACOPOEIA AND NATIONAL FORMULARY AND IN
THE HOMEOPATHIC PHARMACOPOEIA OF THE UNITED STATES, IT IS
SUBJECT TO THE REQUIREMENTS OF THE UNITED STATES
PHARMACOPOEIA AND NATIONAL FORMULARY.

(II) IF THE DRUG IS LABELED AND OFFERED
FOR SALE AS A HOMEOPATHIC DRUG, IT IS SUBJECT TO THE
PROVISIONS OF THE HOMEOPATHIC PHARMACOPOEIA OF THE UNITED
STATES AND NOT TO THOSE OF THE UNITED STATES PHARMACOPOEIA
AND NATIONAL FORMULARY.

REVISOR'S NOTE: This section is new language derived
without substantive change from former Article
43, § 189A.

 

clear space
clear space
white space

Please view image to verify text. To report an error, please contact us.
Session Laws, 1982
Volume 742, Page 1875   View pdf image
 Jump to  
  << PREVIOUS  NEXT >>


This web site is presented for reference purposes under the doctrine of fair use. When this material is used, in whole or in part, proper citation and credit must be attributed to the Maryland State Archives. PLEASE NOTE: The site may contain material from other sources which may be under copyright. Rights assessment, and full originating source citation, is the responsibility of the user.


Tell Us What You Think About the Maryland State Archives Website!



An Archives of Maryland electronic publication.
For information contact mdlegal@mdarchives.state.md.us.

©Copyright  October 11, 2023
Maryland State Archives